Ушбу ишга иқтибос қилган ишлар

2 та иш

Иш: Combined antiangiogenic and anti–PD-L1 therapy stimulates tumor immunity through HEV formation

1. The combination of calreticulin-targeting L-ASNase and anti-PD-L1 antibody modulates the tumor immune microenvironment to synergistically enhance the antitumor efficacy of radiotherapy

   Ying Zhang, V. Akhil, Ho Seong Seo +8

   МақолаCancer Research and TreatmentsTheranostics20240 иқтибос

   ABIABI:AkademIndex/openalex/2024.article.000480

2. Incorporation of immunotherapies and nanomedicine to better normalize angiogenesis-based cancer treatment

   Saade Abdalkareem Jasim, I.M. Farber, Sara Abdalrazzaq M. Noraldeen +7

   МақолаAngiogenesis and VEGF in CancerMicrovascular Research20240 иқтибос

   ABIABI:AkademIndex/openalex/2024.article.003439